National Health Investors Inc（NHI）財務資料NHINational Health Investors Inc

National Health Investors, Inc. (NHI) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Real Estate Investments, accounting for 63.1% of total sales, equivalent to $76.54M. Another important revenue stream is SHOP. Understanding this composition is critical for investors evaluating how NHI navigates market cycles within the Specialized REITs industry.

Evaluating the bottom line, National Health Investors, Inc. maintains a gross margin of 71.46%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 43.09%, while the net margin is 40.22%. These profitability ratios, combined with a Return on Equity (ROE) of 10.92%, provide a clear picture of how effectively NHI converts its operational activities into shareholder value.

In the context of the broader market, NHI competes directly with industry leaders such as HIW and PK. With a market capitalization of $3.23B, it holds a leading position in the sector. When comparing efficiency, NHI's gross margin of 71.46% stands against HIW's 67.58% and PK's 55.61%. Such benchmarking helps identify whether National Health Investors, Inc. is trading at a premium or discount relative to its financial performance.

The company has shown strong revenue growth, with Q2 2026 revenue reaching $121.3 million, up from $105.8 million in Q4 2025. The gross margin has been relatively stable, although it decreased to 69.91% in Q2 2026 from 84.14% in Q4 2024, indicating some pressure on profitability.